Ad. Baron et al., INTERACTIONS BETWEEN INSULIN AND NOREPINEPHRINE ON BLOOD-PRESSURE ANDINSULIN SENSITIVITY - STUDIES IN LEAN AND OBESE MEN, The Journal of clinical investigation, 93(6), 1994, pp. 2453-2462
To explore the interactions between insulin action and norepinephrine
(NE) on blood pressure and muscle vascular resistance, we studied seve
n lean (66+/-1 kg) sensitive and seven age-matched obese (96+/-3 kg) i
nsulin-resistant men after an overnight fast. Both groups were normote
nsive; however, the obese exhibited higher basal blood pressure, 90.8/-2.2 vs. 83.4+/-1.6 mmHg, P < 0.04. Each subject was studied on two s
eparate days during either saline (S) infusion or a euglycemic hyperin
sulinemic clamp (I) achieving insulin concentrations of similar to 70
mu U/ml. After 180 min of either S or I, NE was infused systemically a
t rates of similar to 50, 75, and 100 pg/kg per min. Glucose uptake wa
s measured in whole body ([3-H-3]glucose) and in leg by the balance te
chnique. The results indicate: (a) the NE/pressor dose-response curve
was decreased( shifted to the right) during I in lean but not in obese
subjects, (b) I enhanced NE metabolic clearance by 20% in lean but no
t in obese, (c) NE decreases leg vascular resistance more in lean than
in obese, and (d) NE causes a similar to 20% increase in insulin-medi
ated glucose uptake in both groups. In conclusion, insulin resistance
of obesity is associated with an apparent augmented NE presser sensiti
vity and decreased NE metabolic clearance. Both of these mechanisms ca
n potentially contribute to the higher incidence of hypertension in ob
ese man. Insulin resistance is likely to be a predisposing but not suf
ficient factor in the pathogenesis of hypertension. Because the obese
group exhibited higher basal blood pressure, it is possible that our r
esults reflect this difference. Further studies will be required to cl
arify this issue.